1-14 of 14
Kiyotoshi Imai, MD
Close
Sort by
Journal Articles

Genetic Landscape and Clonal Evolution Following 5-Aza Therapy in Patients with High-Risk Myelodysplastic Syndromes

June Takeda, MD, Yusuke Shiozawa, MD, Yuichi Shiraishi, PhD, Yusuke Okuno, MD PhD, Keisuke Kataoka, MD PhD, Kenichi Chiba, BA, Hiroko Tanaka, BA, Masashi Sanada, MD PhD, Shigeru Chiba, MD, PhD, Norio Asou, MD PhD, Hitoshi Kiyoi, MD PhD, Kiyotoshi Imai, MD PhD, Chikara Hirase, MD PhD, Nobuaki Dobashi, MD, Toru Kiguchi, MD PhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Hideki Makishima, MD PhD FACP., Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Kenichi Yoshida, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4304.
https://doi.org/10.1182/blood.V128.22.4304.4304
Published: 2016
Journal Articles

Clinical Features and Prognosis of Unselected Patients with AML and RAEB-2: Japan Adult Leukemia Study Group CS-07 Study

Yasushi Miyazaki, MD PhD, Sumihisa Honda, PhD, Toru Sakura, MD, Kiyotoshi Imai, MD PhD, Masamitsu Yanada, MD PhD, Kensuke Usuki, MD PhD, Noriko Usui, MD, Ken Takase, MD, Yasutaka Aoyama, MD, PhD, Masashi Sawa, MD, Kazunori Ohnishi, MD PhD, Shigeki Ohtake, MD PhD, Hitoshi Kiyoi, MD PhD, Yukio Kobayashi, MD PhD, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5164.
https://doi.org/10.1182/blood.V128.22.5164.5164
Published: 2016
Journal Articles

Effectiveness of High-Dose MTX Therapy for Adult Ph-Negative ALL By Randomized Trial: JALSG ALL202-O

Toru Sakura, Fumihiko Hayakawa, MD PhD, Isamu Sugiura, MD PhD, Kiyotoshi Imai, MD PhD, Noriko Usui, MD, Shin Fujisawa, MD, Tohru Murayama, Toshiaki Yujiri, MD PhD, Hitoshi Kiyoi, MD PhD, Kazunori Ohnishi, MD PhD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD PhD, Yukio Kobayashi, MD PhD, Keitaro Matsuo, MDPhD, Tomoki Naoe, MD PhD
Journal: Blood
Blood (2015) 126 (23): 79.
https://doi.org/10.1182/blood.V126.23.79.79
Published: 2015
Journal Articles

Genetic Predispositions to Myeloid Neoplasms Caused By Germline DDX41 Mutations

June Takeda, MD, Kenichi Yoshida, MD PhD, Hideki Makishima, MD PhD, Tetsuichi Yoshizato, MD, Yusuke Shiozawa, MD, Yuichi Shiraishi, MD PhD, Yusuke Okuno, MD PhD, Ayana Kon, MD PhD, Yasunobu Nagata, MDPhD, Keisuke Kataoka, MD PhD, Kenichi Chiba, BA, Hiroko Tanaka, BA, Masashi Sanada, MD PhD, Mamiko Sakata-Yanagimoto, MD PhD, Naoshi Obara, MD PhD, Tsuyoshi Nakamaki, MD, Ken Ishiyama, MD PhD, Akira Haigaishi, MDPhD, Shigeru Chiba, MD, PhD, Hiraku Mori, MDPhD, Norio Asou, MD PhD, Hitoshi Kiyoi, MD, Chikara Hirase, MDPhD, Kiyotoshi Imai, MD PhD, Nobuaki Dobashi, MD, Toru Kiguchi, MDPhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Satoru Miyano, MD PhD, Kensuke Usuki, MDPhD, Shuichi Miyawaki, MDPhD, Yoichiro Kamatani, MDPhD, Yukihide Momozawa, MD PhD, Michiaki Kubo, MD PhD, Chantana Polprasert, MD, Jaroslaw P. Maciejewski, MD PhD, Seishi Ogawa, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2843.
https://doi.org/10.1182/blood.V126.23.2843.2843
Published: 2015
Journal Articles

Imatinib-Based Chemotherapy for Newly Diagnosed BCR–ABL Positive Acute Lymphoblastic Leukemia: Japan Adult Leukemia Study Group (JALSG) Ph+ALL208 Study

Shin Fujisawa, MD, Keitaro Matsuo, MD, PhD, Shuichi Mizuta, MD, Hideki Akiyama, MD, Yasunori Ueda, MD PhD, Yasutaka Aoyama, MD, Yoshihiro Hatta, MD, Kazuhiko Kakihana, MD PhD, Nobuaki Dobashi, MD, Isamu Sugiura, MD PhD, Yasushi Onishi, MD PhD, Tomoya Maeda, MD PhD, Kiyotoshi Imai, MD PhD, Shigeki Ohtake, MD PhD, Yasushi Miyazaki, MD, Kazunori Ohnishi, MD PhD, Tomoki Naoe, MDPhD
Journal: Blood
Blood (2014) 124 (21): 932.
https://doi.org/10.1182/blood.V124.21.932.932
Published: 2014
Journal Articles

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Koichiro Minauchi, MD, Masato Obara, MD, PhD, Takahide Ara, MD, Kanako Shima, MD, Atsushi Yasumoto, MD, PhD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Ogasawara, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Imamura, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2697.
https://doi.org/10.1182/blood.V122.21.2697.2697
Published: 2013
Journal Articles

Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib

Naoto Takahashi, MD, PhD, Masatomo Miura, PhD, Jun Kuroki, MD, PhD, Kinuko Mitani, MD, PhD, Atsushi Kitabayashi, MD, PhD, Osamu Sasaki, MD, PhD, Hideo Kimura, MD, PhD, Kiyotoshi Imai, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hideyoshi Noji, MD, PhD, Takeshi Kondo, MD, PhD, Akihisa Kuwayama, MD, PhD, Mutsuhito Motegi, MD, PhD, Yuichi Kato, MD, PhD, Kaoru Takahashi, MD, PhD, Masayuki Mita, MD, PhD, Hajime Saito, MD, PhD, Chikashi Yoshida, MD, PhD, Yoshihiro Torimoto, MD, PhD, Tomofumi Kimura, MD, PhD, Yuji Wano, MD, PhD, Jun Nomura, MD, PhD, Satoshi Yamamoto, MD, PhD, Ko Mayama, MD, PhD, Riko Honma, MD, PhD, Tomohiro Sugawara, MD, PhD, Shinji Sato, MD, PhD, Atsushi Shinagawa, MD, PhD, Akihiko Chubachi, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1360.
https://doi.org/10.1182/blood.V120.21.1360.1360
Published: 2012
Journal Articles

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Minauchi Koichiro, MD, Akio Shigematsu, MD, PhD, Masanobu Nakata, MD, Toshihiro Matsukawa, MD, Koh Ebata, MD, Tomohiro Yamakawa, MD, Tomoyuki Saga, MD, Kanako Shima, MD, Makoto Ibata, MD, PhD, Junichi Sugita, MD, PhD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Masahiro Ogasawara, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Imamura, MD, PhD, Naoki Kobayashi, MD, Ph.D
Journal: Blood
Blood (2011) 118 (21): 4154.
https://doi.org/10.1182/blood.V118.21.4154.4154
Published: 2011
Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D
Journal: Blood
Blood (2010) 116 (21): 2101.
https://doi.org/10.1182/blood.V116.21.2101.2101
Published: 2010
Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3948.
https://doi.org/10.1182/blood.V114.22.3948.3948
Published: 2009
Journal Articles

Phase II Study of Rituximab Combined with Cladribine and Mitoxantrone in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma

Shuichi Ota, MD, Junji Tanaka, MD, Masanobu Nakata, MD, Kiyotoshi Imai, MD, Masahiro Ogasawara, MD, Yoshio Kiyama, MD, Tatsuro Irie, MD, Masanobu Morioka, MD, Shintaro Umehara, MD, Hiroshi Iwasaki, MD, Koji Chiba, MD, Yasutaka Kakinoki, MD, Takashi Fukuhara, MD, Masaharu Kasai, MD, Masahiro Imamura, MD
Journal: Blood
Blood (2008) 112 (11): 4946.
https://doi.org/10.1182/blood.V112.11.4946.4946
Published: 2008
Journal Articles

Large Scale Expansion of Human Dendritic Cells with Regulatory Function from Peripheral Blood Monocytes Employing Leukapheresis and Rapamycin for Clinical Trials.

Masahiro Ogasawara, MD, PhD, Shinsuke Asanuma, MD, Shinsuke Noguchi, MD, Atsushi Yasumoto, MD, Akinori Wada, MD, Shuuichi Ohta, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1204.
https://doi.org/10.1182/blood.V110.11.1204.1204
Published: 2007
Journal Articles

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Koichiro Kobayashi, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2709.
https://doi.org/10.1182/blood.V108.11.2709.2709
Published: 2006
Journal Articles

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Koichiro Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Mitsune Tanimoto, MD, PhD, Masaharu Kasai, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2902.
https://doi.org/10.1182/blood.V108.11.2902.2902
Published: 2006